Magic-angle-spinning NMR of the drug resistant S31N M2 proton transporter from influenza A.

Journal of the American Chemical Society 20120502

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Annals of internal medicine 20120403

The involvement of a Na⁺- and Cl⁻-dependent transporter in the brain uptake of amantadine and rimantadine.

Molecular pharmaceutics 20120402

Chemical, spectroscopic characterization, DFT studies and antibacterial activities in vitro of a new gold(I) complex with rimantadine.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120401

Amantadine and rimantadine for influenza A in children and the elderly.

The Cochrane database of systematic reviews 20120118

Antiviral drugs for influenza.

The Medical letter on drugs and therapeutics 20120109

Kinetics of proton transport into influenza virions by the viral M2 channel.

PloS one 20120101

[The specific features of the cocirculation of influenza viruses in the 2010-2011 postpandemic period according to the results of activities of the D. I. Ivanovsky Research Institute of Virology, Ministry of Health and Social Development of Russia].

Voprosy virusologii 20120101

[Effect of a combination of glutamyl-tryptophan and glycyrrhizic acid on the course of acute infection caused by influenza (H3H2) virus in mice].

Voprosy virusologii 20120101

Cys-loop receptor channel blockers also block GLIC.

Biophysical journal 20111221

Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.

The Journal of infectious diseases 20111215

Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.

Molecules (Basel, Switzerland) 20111208

Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.

Structure (London, England : 1993) 20111109

[Influenza : clinical symptoms, diagnostics and therapy].

Der Internist 20110901

How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?

Journal of the American Chemical Society 20110629

Evaluating how rimantadines control the proton gating of the influenza A M2-proton port via allosteric binding outside of the M2-channel: MD simulations.

Journal of enzyme inhibition and medicinal chemistry 20110401

Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.

Biochimica et biophysica acta 20110201

Resistance characteristics of influenza to amino-adamantyls.

Biochimica et biophysica acta 20110201

Quantitative analysis of influenza M2 channel blockers.

Biochimica et biophysica acta 20110101

[Information of the Center for Ecology and Epidemiology of Influenza, D. I. Ivanovsky Research Institute of Virology, Russian Academy of Medical Sciences, on the results of the 2009-2010 influenza and acute respiratory viral infection epidemic season (at week 40 of 2009 to week 22 of 2010) in the world and Russia].

Voprosy virusologii 20110101

[New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].

Voprosy virusologii 20110101

[In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].

Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20110101

[Comparative pharmacokinetics of antigrippin-maximum administered in capsules and powder for preparing solutions].

Eksperimental'naia i klinicheskaia farmakologiia 20110101

[Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101

Determination of memantine in plasma and vitreous humour by HPLC with precolumn derivatization and fluorescence detection.

Journal of chromatographic science 20110101

[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.

Antiviral research 20101201

Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.

Antiviral research 20101101

Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.

Antiviral research 20101101

Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.

PLoS pathogens 20100901

Magic angle spinning NMR investigation of influenza A M2(18-60): support for an allosteric mechanism of inhibition.

Journal of the American Chemical Society 20100818

Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.

Protein engineering, design & selection : PEDS 20100801

Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.

Obstetrics and gynecology 20100401

Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.

The Pediatric infectious disease journal 20100301

Flu channel drug resistance: a tale of two sites.

Protein & cell 20100301

[Research progress of anti-influenza virus agents].

Yao xue xue bao = Acta pharmaceutica Sinica 20100301

Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.

PloS one 20100101

[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].

Voprosy virusologii 20100101

A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from mainland China between 1956 and 2009.

Antiviral therapy 20100101

[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20100101

Update: influenza activity - United States, August 30-October 31, 2009.

MMWR. Morbidity and mortality weekly report 20091113

Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.

Biochemical and biophysical research communications 20091016

Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.

American journal of physiology. Cell physiology 20091001

[Do we really need antiflu virus medication?].

Medecine et maladies infectieuses 20090901

Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.

Journal of theoretical biology 20090707

Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.

Bioorganic & medicinal chemistry 20090215

Influenza.

BMJ clinical evidence 20090101

[The 24 May, 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21, 2009, and its deposit in the state collection of viruses (SCV No. 2452 dated May 24, 2009)].

Voprosy virusologii 20090101

[Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents].

Voprosy virusologii 20090101

[The characteristics of epidemic influenza A and B virus strains circulating in Russia during the 2007-2008 season].

Voprosy virusologii 20090101

Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.

Drugs 20090101

[New betulin derivatives in combination with rimantadine for inhibition of influenza virus reproduction].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.

Hepatology (Baltimore, Md.) 20081201

How amantadine and rimantadine inhibit proton transport in the M2 protein channel.

Journal of molecular graphics & modelling 20081001

Antivirals and influenza: frequency of resistance.

The Pediatric infectious disease journal 20081001

Design and synthesis of bioactive 1,2-annulated adamantane derivatives.

Organic & biomolecular chemistry 20080907

Antiviral activity of nano carbon fullerene lipidosome against influenza virus in vitro.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20080601

Determination of rimantadine in rat plasma by liquid chromatography/electrospray mass spectrometry and its application in a pharmacokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080315

Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.

Journal of medicinal chemistry 20080313

Influenza.

Canadian family physician Medecin de famille canadien 20080301

Influenza guideline for South Africa--update 2008.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20080301

Structure and mechanism of the M2 proton channel of influenza A virus.

Nature 20080131

Amantadine and rimantadine for influenza A in children and the elderly.

The Cochrane database of systematic reviews 20080123

[Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].

Molekuliarnaia genetika, mikrobiologiia i virusologiia 20080101

[Epidemic strains influenza viruses A and B in the 2005-2006 season in Russia].

Voprosy virusologii 20080101

[The first break-through of the genotype 2.3.2 of high-virulence influenza A virus A/HSN1, which is new for Russia, in the Far East].

Voprosy virusologii 20080101

[The spread and biological properties of epidemic influenza viruses A and B strains circulating in the 2006-2007 season in Russia].

Voprosy virusologii 20080101

[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20080101

[Antiviral treatment of influenza in humans].

Therapeutische Umschau. Revue therapeutique 20071101

Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Protein science : a publication of the Protein Society 20071001

New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma.

Journal of pharmaceutical and biomedical analysis 20070903

The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006.

Antiviral research 20070801

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

The Journal of infectious diseases 20070715

Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.

Journal of the American Geriatrics Society 20070601

Antiviral therapy and prophylaxis for influenza in children.

Pediatrics 20070401

Influenza: evolving strategies in treatment and prevention.

Seminars in respiratory and critical care medicine 20070401

Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.

Cutis 20070301

Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.

International journal of chronic obstructive pulmonary disease 20070301

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

Antiviral research 20070201

Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.

Bioorganic & medicinal chemistry letters 20070201

[Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].

Voprosy virusologii 20070101

[Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine].

Eksperimental'naia i klinicheskaia farmakologiia 20070101

No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20070101

[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models].

Eksperimental'naia i klinicheskaia farmakologiia 20070101

Antivirals for the treatment and prevention of epidemic and pandemic influenza.

Influenza and other respiratory viruses 20070101

Amantadine may be lifesaving in severe influenza A.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061115

Which agents should we use to treat and prevent influenza in 2006-2007?

Cleveland Clinic journal of medicine 20061101

Antiviral management of seasonal and pandemic influenza.

The Journal of infectious diseases 20061101

Recommended composition of influenza virus vaccines for use in the 2007 influenza season.

Releve epidemiologique hebdomadaire 20061013

[The use of 'Antigrippin-maximum' in the complex therapy of patients with acute respiratory diseases].

Voenno-meditsinskii zhurnal 20061001

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

The Journal of infectious diseases 20060615

Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.

Medical microbiology and immunology 20060601

Heterocyclic rimantadine analogues with antiviral activity.

Bioorganic & medicinal chemistry 20060515

A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.

Virology 20060510

Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.

Biomedical chromatography : BMC 20060501

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Amantadine and rimantadine for influenza A in adults.

The Cochrane database of systematic reviews 20060419

Antiviral resistance in influenza viruses--implications for management and pandemic response.

The New England journal of medicine 20060223

[Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].

Revue medicale suisse 20060125

[Characterization of epidemic influenza virus A(H3N2) strains circulating in Russia in the 2003-2004 epidemic season].

Voprosy virusologii 20060101

[Molecular genetic analysis of the biological properties of highly pathogenic influenza A/H5N1 virus strains isolated from wild birds and poultry during epizooty in Western Siberia (July 2005)].

Voprosy virusologii 20060101

[In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005].

Voprosy virusologii 20060101

Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20060101

HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine.

The Annals of pharmacotherapy 20060101

[Study of highly pathogenic H5N1 influenza virus isolated from sick and dead birds in Western Siberia].

Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20060101

[Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1].

Voprosy virusologii 20060101

Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.

Antiviral chemistry & chemotherapy 20060101

[The properties of the epidemic influenza viruses A and B strains circulating in Russia in the 2004-2005 epidemic season].

Voprosy virusologii 20060101

[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus].

Pneumonologia i alergologia polska 20060101

Antiviral drugs for prophylaxis and treatment of influenza.

The Medical letter on drugs and therapeutics 20051121

Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies.

Biomedical chromatography : BMC 20051101

[Determination of rimantadine hydrochloride in compound rimantadine hydrochloride capsules by capillary gas chromatography].

Se pu = Chinese journal of chromatography 20051101

Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.

Movement disorders : official journal of the Movement Disorder Society 20050701

Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene.

Molecular endocrinology (Baltimore, Md.) 20050501

I wish to comment on several points in the recent 'Guidelines'.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20050501

A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults.

American journal of infection control 20050501

Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.

Journal of chromatographic science 20050401

Statement on travel, influenza, and prevention.

Canada communicable disease report = Releve des maladies transmissibles au Canada 20050315

Antiviral drugs for prophylaxis and treatment of influenza.

Obstetrics and gynecology 20050201

[The rimantadine sensitivity spectrum in influenza A viruses circulating in the 2002-2004 epidemic seasons].

Voprosy virusologii 20050101

Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.

Journal of the American Medical Directors Association 20050101

Influenza.

Clinical evidence 20041201

Pandemic influenza: is an antiviral response realistic?

The Pediatric infectious disease journal 20041101

Antiviral drugs for prophylaxis and treatment of influenza.

The Medical letter on drugs and therapeutics 20041025

Avian influenza should be ruffling our feathers.

The Lancet. Infectious diseases 20041001

What is the best antiviral agent for influenza infection?

American family physician 20041001

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040901

Avian influenza: a new pandemic threat?

Mayo Clinic proceedings 20040401

Validation of a capillary zone electrophoresis method for determination of rimantadine hydrochloride in Rimantadin100 tablets and the method application to dissolution test monitoring.

Drug development and industrial pharmacy 20040201

Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.

Arzneimittel-Forschung 20040101

Amantadine and rimantadine for preventing and treating influenza A in adults.

The Cochrane database of systematic reviews 20040101

Heterocyclic rimantadine analogues with antiviral activity.

Bioorganic & medicinal chemistry 20031201

Influenza.

Clinical evidence 20031201

A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.

Canadian respiratory journal 20031001

Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

Annals of internal medicine 20030902

Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.

Annals of internal medicine 20030902

Review of the use of neuraminidase inhibitors for prophylaxis of influenza.

Communicable disease and public health 20030601

Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.

Antiviral therapy 20030601

Are the 2-isomers of the drug rimantadine active anti-influenza A agents?

Antiviral chemistry & chemotherapy 20030501

[Antiviral agents for influenza].

Nihon rinsho. Japanese journal of clinical medicine 20030201

[Treatment of influenza in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics 20030201

Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030101

Combined protective effect of a fungal Cu/Zn-containing superoxide dismutase and rimantadine hydrochloride in experimental murine influenza a virus infection.

Acta virologica 20030101

[Structure and antiviral activity of adamantane-containing polymer preparation].

Voprosy virusologii 20030101

Reduction of the influenza burden in children.

Pediatrics 20021201

Influenza.

Clinical evidence 20021201

Current strategies for management of influenza in the elderly population.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020915

Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.

Annals of internal medicine 20020820

Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis.

Annals of internal medicine 20020820

Development of a novel influenza A antiviral assay.

Journal of virological methods 20020801

Nosocomial transmission of influenza.

Occupational medicine (Oxford, England) 20020801

Influenza.

Clinical evidence 20020601

Influenza surveillance with rapid diagnostic tests.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020515

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20020412

Antiviral therapy of influenza.

Seminars in pediatric infectious diseases 20020401

Influenza in the acute hospital setting.

The Lancet. Infectious diseases 20020301

Drugs for non-HIV viral infections.

The Medical letter on drugs and therapeutics 20020204

Anti-influenza therapies.

Virus research 20020130

Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.

Electrophoresis 20020101

[Changes in phospholipid components of pulmonary surfactant in experimental influenza infection and their correction by remantadin and deitiforine].

Voprosy virusologii 20020101

Antiviral therapy for influenza virus infections.

Seminars in pediatric infectious diseases 20020101

Amantadine and rimantadine for preventing and treating influenza A in adults.

The Cochrane database of systematic reviews 20020101

Antivirals for influenza: what is their role in the older patient?

Drugs & aging 20020101

[3-substituted analogs of remantadine: synthesis and antiherpetic activity in Vero cells].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

Neuraminidase inhibitors in patients with underlying airways disease.

American journal of respiratory medicine : drugs, devices, and other interventions 20020101

Perspectives on antiviral use during pandemic influenza.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229

Vaccines for pneumonia and new antiviral therapies.

The Medical clinics of North America 20011101

Ileoanal pouch function is related to postprandial pouch tone.

The British journal of surgery 20011101

ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices.

American family physician 20011001

Adverse cutaneous reactions to influenza vaccinations and chemotherapy.

International journal of dermatology 20010701

Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs.

The Journal of general virology 20010601

Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration.

International journal of clinical pharmacology and therapeutics 20010401

Managing influenza: amantadine, rimantadine and beyond.

International journal of clinical practice 20010401

Amantadine and rimantadine for preventing and treating influenza A in adults.

The Cochrane database of systematic reviews 20010101

Prophylaxis and treatment of influenza virus infection.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20010101

Free radical lipid peroxidation and monooxygenase activity in experimental influenza virus infection after treatment with rimantadine.

Advances in experimental medicine and biology 20010101

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.

Archives of internal medicine 20000522

Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990.

Antimicrobial agents and chemotherapy 19931001

Synthesis and antiviral activity of metabolites of rimantadine.

Journal of medicinal chemistry 19900701

Rimantadine and seizures.

Annals of internal medicine 19890215

Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

Antimicrobial agents and chemotherapy 19840101

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults.

Antimicrobial agents and chemotherapy 19810201

Enhancement of activity against influenza viruses by combinations of antiviral agents.

Antimicrobial agents and chemotherapy 19801001

Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.

Journal of virology 19800201